This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Thuys, C. Articles by Augustin, S. Search for Related Content PubMed PubMed Citation Articles by Thuys, C. Articles by Augustin, S. Social Bookmarking                   What's this?

New technology increases perioperative haemoglobin levels for paediatric cardiopulmonary bypass: what is the benefit?

Cardiac Surgery Unit, Royal Children’s Hospital, Melbourne, Australia, clarke.thuys{at}rch.org.au

Stephen Horton

Cardiac Surgery Unit, Royal Children’s Hospital, Melbourne, Australia, Department of Medicine, University of Melbourne, Melbourne, Australia

Martin Bennett

Cardiac Surgery Unit, Royal Children’s Hospital, Melbourne, Australia

Simon Augustin

Cardiac Surgery Unit, Royal Children’s Hospital, Melbourne, Australia

Increasing perioperative haemoglobin level by reducing priming volume and maintaining a safe cardiopulmonary bypass (CPB) system is the aim of every perfusionist. In this study, we have compared the two membrane oxygenators and pump systems used for paediatric bypass at the Royal Children’s Hospital on a regular basis since 1988. We looked at all patients who had the Cobe VPCML (Cobe Laboratories, Denver, CO, USA) and Terumo RX-05 (Terumo Corporation, Tokyo, Japan) oxygenators used for flows from 800 mL/min up to the maximum rated flow for the respective oxygenator from January 2002 until March 2004. The VPCML refers to using only the 0.4-m² section of the oxygenator. The pump systems used were the Stöckert CAPS (Stöckert Instrumente GmbH, Munich, Germany) and Jostra HL 30 (Jostra AB, Lund, Sweden). Changing from the VPCML to the RX-05 resulted in a 37% reduction in priming volume. The introduction of the Jostra HL 30 with a custom-designed mast system reduced the priming volume by another 15%. This change in priming volume allowed a significant increase, from 6 to 34%, in the percentage of patients who received bloodless primes, and for those patients who received blood primes, an increase in haemoglobin (Hb) on bypass from 8.2 to 9.6 g/dL, on average.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?